rethinkPeptides Search
Menu
Study breakdown

How Nerve-Driven Inflammation Causes Spinal Disc Degeneration

Narrative ReviewModerate evidence
The takeaway

Neuropeptides substance P and CGRP released by nerve fibers growing into degenerating spinal discs drive neurogenic inflammation that accelerates disc breakdown.

Substance P + CGRP drive disc breakdown

Neuropeptides released by nerve fibers growing into degenerating spinal discs create a vicious inflammatory cycle that accelerates degeneration

What the researchers found

Neurogenic inflammation driven by substance P and CGRP from ingrowing nociceptive nerve fibers plays a crucial role in intervertebral disc degeneration, with non-neuronal cells also contributing.

Why it matters

Back pain from disc degeneration is one of the leading causes of disability worldwide. Understanding the neurogenic inflammation cycle could lead to targeted treatments that break the cycle and slow disc breakdown.

The numbers in context

Reviews substance P and CGRP release from nociceptive nerve fibers. Non-neuronal cells (disc cells, immune cells) express functional neuropeptide receptors. TRP channels contribute to neurogenic inflammation.

How the study worked

Review article synthesizing evidence on neurogenic inflammation mechanisms in intervertebral disc degeneration.

Who was studied

Not applicable (review of disc degeneration biology)

What this study cannot tell us

Review of existing literature — no new experimental data. The relative contribution of neurogenic versus other forms of inflammation in disc degeneration is still debated.

How to read the evidence

Narrative review synthesizing preclinical and clinical evidence. Provides a comprehensive mechanistic framework but specific therapeutic implications remain to be tested.

When this study was published

Published in 2025, incorporating recent findings on non-neuronal cell contributions to neurogenic inflammation in discs.

The bigger picture

The same neuropeptides (substance P, CGRP) implicated in migraine are now shown to drive spinal disc degeneration, suggesting anti-neuropeptide therapies could have applications in back pain.

Questions still open

  • Could anti-CGRP or anti-substance P therapies slow disc degeneration?
  • What triggers the initial nerve ingrowth into degenerating discs?

Common questions

What is neurogenic inflammation in the spine?
Neurogenic inflammation occurs when nerve fibers release inflammatory neuropeptides (substance P and CGRP) directly into tissue. In degenerating spinal discs, new nerve fibers grow inward and release these peptides, causing inflammation that further damages the disc.
Could migraine drugs help with back pain?
Theoretically, since the same neuropeptides (CGRP, substance P) are involved in both migraine and disc degeneration. However, this has not been tested, and delivering these drugs to spinal discs presents different challenges than treating headache.

Read the original research

Role of neurogenic inflammation in intervertebral disc degeneration.

World journal of orthopedics, 16(1), 102120

Citation

Peng, Bao-Gan; Li, Yong-Chao; Yang, Liang. (2025). Role of neurogenic inflammation in intervertebral disc degeneration.. World journal of orthopedics, 16(1), 102120. https://doi.org/10.5312/wjo.v16.i1.102120